Related Experiment Videos
[Vaginal colonization of Streptococcus B in pregnancy]
A Citernesi1, G Formica, S Caruso
1Divisione di Ostetricia e Ginecologia, Ospedale Misericordia e Dolce, Prato.
Insights
Group B Streptococcus (GBS) causes significant neonatal sepsis. Screening pregnant women for GBS colonization and providing intrapartum chemoprophylaxis to positive cases is crucial for preventing neonatal infections.
Area of Science:
- Obstetrics and Gynecology
- Neonatal Medicine
- Infectious Diseases
Context:
- Group B Streptococcus (GBS) is a leading cause of serious neonatal sepsis, exceeding other congenital infections.
- Asymptomatic maternal genital tract colonization is the primary mode of GBS transmission to neonates.
- Existing antenatal screening protocols do not adequately address GBS.
Purpose:
- To assess the epidemiological situation of GBS colonization and neonatal transmission in Tuscany.
- To evaluate the prevalence of GBS in pregnant women and neonates.
- To inform preventive strategies against neonatal sepsis.
Summary:
- A study in Tuscany screened 5079 pregnant women for vaginal GBS colonization (6.6% positive) and 3654 mother-neonate pairs for transmission.
- GBS transmission to neonates occurred in 20% of positive mothers; 33% of positive neonates were born to GBS-negative mothers.
- Culture methods may underestimate GBS prevalence, highlighting the need for improved detection and prevention.
Impact:
- The high prevalence of GBS in mothers and neonates necessitates urgent preventive measures.
- Findings support implementing antenatal GBS screening via vaginal culture at 36 weeks gestation.
- Intrapartum chemoprophylaxis for GBS-positive mothers is recommended to reduce neonatal sepsis rates.
Abstract:
In the last few years the importance of GBS as the cause of serious neonatal sepsis has become more evident. The number of cases of this infection clearly exceeds the number of other congenital infections, for which antenatal screening is performed. Asymptomatic colonization of the genital tract of the pregnant woman has the most important role in transmission of GBS and several risk factors are connected to neonatal infection. In order to assess the epidemiological situation in Tuscany, 5079 pregnant women have been recruited by the Obstetrical Department of 16 Hospitals and evaluated for the vaginal colonization by GBS. 3654 couples mother-neonate have also been studied to ascertain the transmission of this germ to the neonate. A vaginal swab was collected at the admission to the Hospital at delivery-time and swabs from several sites of the neonate were obtained just after birth. A blood-agar culture and a latex agglutination test were employed to detect the GBS. GBS was present in 6.6% of the vaginal cultures, with a wide variation in colonization rates. 2.2% of the neonates were positive. The transmission of GBS from the positive mother to the neonate occurred in 20% of the cases. Furthermore one positive neonate out of three was born from a negative mother. No correlation between GBS positivity and preterm delivery was found. The rates of prevalence of GBS in our population, both mother and neonates, suggest a situation that can no longer be neglected. Our data are probably underestimated because of the low sensibility of the culture method. A preventive strategy has to be employed to avoid serious neonatal sepsis. An antenatal screening that provides a vaginal culture at the 36th week of gestation and a chemoprophylaxis intra-partum in the positive cases appears to be the most effective approach.